These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 25403620
21. Effect of Montelukast on Spinal Cord Ischemia- Reperfusion Injury. Korkmaz K, Gedik HS, Budak AB, Yener AU, Kaya E, Genc SB, Cagli K. Turk Neurosurg; 2015; 25(5):757-65. PubMed ID: 26442542 [Abstract] [Full Text] [Related]
23. Inhibition of sepsis-induced pancreatic injury by leukotriene receptor antagonism via modulation of oxidative injury, and downregulation of inflammatory markers in experimental rats. Hagar HH, Alhazmi SM, Arafah M, Bayoumy NM. Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3425-3435. PubMed ID: 37962585 [Abstract] [Full Text] [Related]
24. Cysteinyl leukotriene receptor antagonism alleviates renal injury induced by ischemia-reperfusion in rats. Hagar HH, Abd El Tawab R. J Surg Res; 2012 Nov; 178(1):e25-34. PubMed ID: 22487384 [Abstract] [Full Text] [Related]
25. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast. Sener G, Sehirli O, Cetinel S, Ercan F, Yüksel M, Gedik N, Yeğen BC. Prostaglandins Leukot Essent Fatty Acids; 2005 Dec; 73(6):453-62. PubMed ID: 16162403 [Abstract] [Full Text] [Related]
26. Curcumin Attenuates Inflammation, Oxidative Stress, and Ultrastructural Damage Induced by Spinal Cord Ischemia-Reperfusion Injury in Rats. Gokce EC, Kahveci R, Gokce A, Sargon MF, Kisa U, Aksoy N, Cemil B, Erdogan B. J Stroke Cerebrovasc Dis; 2016 May; 25(5):1196-1207. PubMed ID: 26935117 [Abstract] [Full Text] [Related]
27. Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats. Ibrahim MA, Amin EF, Ibrahim SA, Abdelzaher WY, Abdelrahman AM. Eur J Pharmacol; 2014 Feb 05; 724():204-10. PubMed ID: 24370493 [Abstract] [Full Text] [Related]
28. LC-MS/MS profiling and neuroprotective effects of Mentat® against transient global ischemia and reperfusion-induced brain injury in rats. Viswanatha GL, Kumar LM, Rafiq M, Kavya KJ, Thippeswamy AH, Yuvaraj HC, Azeemuddin M, Anturlikar SD, Patki PS, Babu UV, Ramakrishnan S. Nutrition; 2015 Feb 05; 31(7-8):1008-17. PubMed ID: 26059376 [Abstract] [Full Text] [Related]
29. The protective effect of zeranol in cerebral ischemia reperfusion via p-CREB overexpression. Mohamed SK, Ahmed AAE, El Morsy EM, Nofal S. Life Sci; 2019 Jan 15; 217():212-221. PubMed ID: 30550883 [Abstract] [Full Text] [Related]
30. Α‑lipoic acid protects against cerebral ischemia/reperfusion-induced injury in rats. Deng H, Zuo X, Zhang J, Liu X, Liu L, Xu Q, Wu Z, Ji A. Mol Med Rep; 2015 May 15; 11(5):3659-65. PubMed ID: 25572614 [Abstract] [Full Text] [Related]
31. Sitagliptin attenuates transient cerebral ischemia/reperfusion injury in diabetic rats: implication of the oxidative-inflammatory-apoptotic pathway. El-Sahar AE, Safar MM, Zaki HF, Attia AS, Ain-Shoka AA. Life Sci; 2015 Apr 01; 126():81-6. PubMed ID: 25721294 [Abstract] [Full Text] [Related]
32. Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia. Khan M, Elango C, Ansari MA, Singh I, Singh AK. J Neurochem; 2007 Jul 01; 102(2):365-77. PubMed ID: 17437550 [Abstract] [Full Text] [Related]
33. Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats. Otunctemur A, Ozbek E, Cakir SS, Dursun M, Cekmen M, Polat EC, Ozcan L, Somay A, Ozbay N. Int Braz J Urol; 2015 Jul 01; 41(2):279-87. PubMed ID: 26005969 [Abstract] [Full Text] [Related]
34. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats. Zhao R, Shi WZ, Zhang YM, Fang SH, Wei EQ. J Pharm Pharmacol; 2011 Apr 01; 63(4):550-7. PubMed ID: 21401607 [Abstract] [Full Text] [Related]
35. The protective role of montelukast against intestinal ischemia-reperfusion injury in rats. Wu S, Zhu X, Jin Z, Tong X, Zhu L, Hong X, Zhu X, Liu P, Shen W. Sci Rep; 2015 Oct 26; 5():15787. PubMed ID: 26497763 [Abstract] [Full Text] [Related]
36. Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat. Sener G, Sehirli O, Toklu H, Ercan F, Alican I. J Pharm Pharmacol; 2007 Jun 26; 59(6):837-42. PubMed ID: 17637175 [Abstract] [Full Text] [Related]
37. Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats. Holma R, Salmenperä P, Riutta A, Virtanen I, Korpela R, Vapaatalo H. Eur J Pharmacol; 2001 Oct 19; 429(1-3):309-18. PubMed ID: 11698051 [Abstract] [Full Text] [Related]
38. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling. Lai J, Mei ZL, Wang H, Hu M, Long Y, Miao MX, Li N, Hong H. Neurochem Int; 2014 Sep 19; 75():26-31. PubMed ID: 24879954 [Abstract] [Full Text] [Related]
39. Mechanisms underlying the protective effect of leukotriene receptor antagonist montelukast against doxorubicin induced testicular injury in rats. Mohamed MZ, Zenhom NM. Prostaglandins Other Lipid Mediat; 2020 Aug 19; 149():106447. PubMed ID: 32173485 [Abstract] [Full Text] [Related]
40. Neuroprotective Effect of Fisetin Against the Cerebral Ischemia-Reperfusion Damage via Suppression of Oxidative Stress and Inflammatory Parameters. Zhang P, Cui J. Inflammation; 2021 Aug 19; 44(4):1490-1506. PubMed ID: 33616827 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]